Mental Health, Substance Use, and Tuberculosis Preventive Therapy in People With HIV: A Prospective Cohort Study - Scorecard - MDSpire

Mental Health, Substance Use, and Tuberculosis Preventive Therapy in People With HIV: A Prospective Cohort Study

  • By

  • Ann E Johnson

  • Lucy Chimoyi

  • Sheela Shenoi

  • Marie A Brault

  • Laura Forastiere

  • Salome Charalambous

  • Violet Chihota

  • J Lucian Davis

  • June 4, 2025

  • 0 min

Share

Clinical Scorecard: Impact of Mental Health and Substance Use on Tuberculosis Preventive Therapy Adherence Among Individuals With HIV

At a Glance

CategoryDetail
ConditionTuberculosis preventive therapy (TPT) adherence among people with HIV (PWHIV)
Key MechanismsMental health disorders (depression, anxiety) and substance use (alcohol, tobacco) influence TPT adherence and completion
Target PopulationPeople with HIV initiating 3-month isoniazid–rifapentine (3HP) TPT regimen
Care SettingCommunity Health Centers in Johannesburg, South Africa

Key Highlights

  • Depression symptoms were common (36%) and independently associated with 9% lower TPT adherence and reduced completion odds (OR 0.48).
  • Anxiety symptoms, unhealthy alcohol use (34%), and tobacco use (27%) were prevalent but not independently linked to TPT adherence or completion.
  • Participant narratives emphasized the negative impact of mental health on adherence and the need for integrated social and psychological support.

Guideline-Based Recommendations

Diagnosis

  • Screen PWHIV initiating TPT for depression using PHQ-9 and anxiety using GAD-7.
  • Assess alcohol use with AUDIT-C and substance use with ASSIST.

Management

  • Refer patients with moderate to severe depression (PHQ-9 ≥10), anxiety (GAD-7 ≥10), or suicidality to social workers and psychologists for support.
  • Implement integrated mental health and substance use interventions alongside TPT.

Monitoring & Follow-up

  • Use electronic medication-event reminder monitors (MERM) to objectively measure TPT adherence.
  • Regularly reassess mental health and substance use symptoms during TPT.

Risks

  • Depression significantly increases risk of TPT nonadherence and noncompletion.
  • Unhealthy alcohol and tobacco use are common but require further study for direct impact on TPT outcomes.

Patient & Prescribing Data

224 PWHIV on ART initiating 3HP TPT in South Africa

Only 50% completed TPT; depression symptoms were the strongest predictor of lower adherence and completion.

Clinical Best Practices

  • Incorporate routine mental health and substance use screening into TPT initiation protocols.
  • Provide targeted psychological and social support to patients with depression to improve TPT adherence.
  • Utilize electronic adherence monitoring to identify and address nonadherence early.
  • Recognize the high prevalence of mental health and substance use disorders among PWHIV and address these comorbidities holistically.

References

Original Source(s)

Related Content